I am in total agreement with you across the board.
The one area I want to stress for possible new eyes is your reference to the value you came up with for IPIX should Brilacidin become the "Gold Standard Treatment for CV19" and which you posted within the last number of months.
Your value was based on extremely conservative values for all factors relating to IPIX/CV and the value at which you arrived was JUST for treatment in the USA. Note that "new eyes" - it was ONLY for treatment in the USA. Extrapolate out what it would become if you add in the rest of the world and when you do have some oxygen ready.
When you made this original "value" post we were much earlier in having such positive expectations that Brilacidin would reach the point it is today with the published SI of 426, near 100% viral kill w/ Rem...., and the belief by some in the virology field that believe it has the possibility to become the world's greatest treatment for ALL viruses. Will it reach this pinnacle, who knows, but the RBL test results show it is a serious contender for such a finding.
The point I am trying to make is that some "new eyes" may get glassy at mentions of $20,30, 50 per share but in reality the upper end value is currently in the strong triple digit range when you look at Brilacidin and the TOTAL REVENUE STREAMS it could/will be addressing across the many broad spectrums that we already know it will address (IBD, GI tract in toto, pulmonary to include COPD/Athsma/Bronchitis/others, kidney, encephalitic issues, dermatology uses, etc) and the many additonal uses not currently known or only thought to be possible uses such as cystic fibrosis and for which further testing will have to be done to proceed any further than just the discussion phase.
The financial position of IPIX at the start of the the year made all these opportunities look like merely dreams, but today's financial condition and the expectation of many near term grants and collaborations with possible partners and drugs makes the future look extremely positive that all these indications will be able to be addressed and possibly brought to the stage of being able to help mankind.
I am not giving any upper end numbers as we are not there yet. But be aware that unloading all your shares once a hefty share price is reached (and hefty to you today may be anything over $10 to $50) would be quite profitable but in the long run very foolish.
Know what you own. Know that all current stock pricing is artificially tanked at the current time and that we are on the doorstep of bringing into the headlights of mainstream medicine perhaps the greatest drug ever developed. Not there yet but indications seem to indicate Brilacidin is the real deal.
As a final statement of fact that such a scenario as described above could happen, Regeneron is one of the newest BPs (hint: look up it's share price) and all it had when it started was thalidomide (yes, the drug that deformed all the babies back in the 60s or so) and it built a fortune around this drug and it's many positive abilities (just don't give it to pregnant women). I believe Brilacidin dwarfs thalidomide in comparative abilities so our potential is much greater. Just something to keep in mind.
KNOW WHAT YOU OWN
The one area I want to stress for possible new eyes is your reference to the value you came up with for IPIX should Brilacidin become the "Gold Standard Treatment for CV19" and which you posted within the last number of months.
Your value was based on extremely conservative values for all factors relating to IPIX/CV and the value at which you arrived was JUST for treatment in the USA. Note that "new eyes" - it was ONLY for treatment in the USA. Extrapolate out what it would become if you add in the rest of the world and when you do have some oxygen ready.
When you made this original "value" post we were much earlier in having such positive expectations that Brilacidin would reach the point it is today with the published SI of 426, near 100% viral kill w/ Rem...., and the belief by some in the virology field that believe it has the possibility to become the world's greatest treatment for ALL viruses. Will it reach this pinnacle, who knows, but the RBL test results show it is a serious contender for such a finding.
The point I am trying to make is that some "new eyes" may get glassy at mentions of $20,30, 50 per share but in reality the upper end value is currently in the strong triple digit range when you look at Brilacidin and the TOTAL REVENUE STREAMS it could/will be addressing across the many broad spectrums that we already know it will address (IBD, GI tract in toto, pulmonary to include COPD/Athsma/Bronchitis/others, kidney, encephalitic issues, dermatology uses, etc) and the many additonal uses not currently known or only thought to be possible uses such as cystic fibrosis and for which further testing will have to be done to proceed any further than just the discussion phase.
The financial position of IPIX at the start of the the year made all these opportunities look like merely dreams, but today's financial condition and the expectation of many near term grants and collaborations with possible partners and drugs makes the future look extremely positive that all these indications will be able to be addressed and possibly brought to the stage of being able to help mankind.
I am not giving any upper end numbers as we are not there yet. But be aware that unloading all your shares once a hefty share price is reached (and hefty to you today may be anything over $10 to $50) would be quite profitable but in the long run very foolish.
Know what you own. Know that all current stock pricing is artificially tanked at the current time and that we are on the doorstep of bringing into the headlights of mainstream medicine perhaps the greatest drug ever developed. Not there yet but indications seem to indicate Brilacidin is the real deal.
As a final statement of fact that such a scenario as described above could happen, Regeneron is one of the newest BPs (hint: look up it's share price) and all it had when it started was thalidomide (yes, the drug that deformed all the babies back in the 60s or so) and it built a fortune around this drug and it's many positive abilities (just don't give it to pregnant women). I believe Brilacidin dwarfs thalidomide in comparative abilities so our potential is much greater. Just something to keep in mind.
KNOW WHAT YOU OWN
16
